Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Daniels

Showing results (431-440 of 503) with videos related to

Pageof 51
Sort By:
Advances in Radiation Oncology|November 29, 2024
Five-Year Prostate-Specific Membrane Antigen Positron Emission Tomography-Based Outcomes of Spot-Scanning Proton Radiation Therapy for Localized Prostate Cancer: A Single Institution ExperienceWill Sperduto, Molly M Voss, Brady Laughlin, et al.
American Journal of Ophthalmology|March 28, 2007
Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri)Anthony B Daniels, Grant T Liu, Nicholas J Volpe, et al.
Investigative Ophthalmology & Visual Science|March 19, 2019
Rabbit Model of Intra-Arterial Chemotherapy Toxicity Demonstrates Retinopathy and Vasculopathy Related to Drug and Dose, Not Procedure or ApproachAnthony B Daniels, Michael T Froehler, Amy H Nunnally, et al.
European Heart Journal|August 12, 2025
High-sensitivity point-of-care measurement of cardiac troponinLouise Cullen, Johannes Mair, Ola Hammarsten, et al.
Investigative Ophthalmology & Visual Science|November 10, 2021
Intravitreal HDAC Inhibitor Belinostat Effectively Eradicates Vitreous Seeds Without Retinal Toxicity In Vivo in a Rabbit Retinoblastoma ModelJessica V Kaczmarek, Carley M Bogan, Janene M Pierce, et al.
American Heart Journal|February 2, 2020
Incidence, underlying conditions, and outcomes of patients receiving acute renal replacement therapies in tertiary cardiac intensive care units: An analysis from the Critical Care Cardiology Trials Network RegistrySean van Diepen, Wayne Tymchak, Erin A Bohula, et al.
Nature|April 7, 2022
Multifunctional biocatalyst for conjugate reduction and reductive aminationThomas W Thorpe, James R Marshall, Vanessa Harawa, et al.
Translational Vision Science & Technology|September 8, 2021
Efficacy, Toxicity, and Pharmacokinetics of Intra-Arterial Chemotherapy Versus Intravenous Chemotherapy for Retinoblastoma in Animal Models and PatientsAnthony B Daniels, Michael T Froehler, Jessica V Kaczmarek, et al.
Journal of the American College of Cardiology|November 3, 2022
Implementation of High-Sensitivity Cardiac Troponin Assays in the United StatesCian McCarthy, Shuang Li, Tracy Y Wang, et al.
Medical Physics|September 10, 2019
Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC)Chenbin Liu, Nathan Y Yu, Jie Shan, et al.
Pageof 51

Showing results (431-440 of 503) with videos related to

Sort By:
Pageof 51
Advances in Radiation Oncology|November 29, 2024
Five-Year Prostate-Specific Membrane Antigen Positron Emission Tomography-Based Outcomes of Spot-Scanning Proton Radiation Therapy for Localized Prostate Cancer: A Single Institution ExperienceWill Sperduto, Molly M Voss, Brady Laughlin, et al.
American Journal of Ophthalmology|March 28, 2007
Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri)Anthony B Daniels, Grant T Liu, Nicholas J Volpe, et al.
Investigative Ophthalmology & Visual Science|March 19, 2019
Rabbit Model of Intra-Arterial Chemotherapy Toxicity Demonstrates Retinopathy and Vasculopathy Related to Drug and Dose, Not Procedure or ApproachAnthony B Daniels, Michael T Froehler, Amy H Nunnally, et al.
European Heart Journal|August 12, 2025
High-sensitivity point-of-care measurement of cardiac troponinLouise Cullen, Johannes Mair, Ola Hammarsten, et al.
Investigative Ophthalmology & Visual Science|November 10, 2021
Intravitreal HDAC Inhibitor Belinostat Effectively Eradicates Vitreous Seeds Without Retinal Toxicity In Vivo in a Rabbit Retinoblastoma ModelJessica V Kaczmarek, Carley M Bogan, Janene M Pierce, et al.
American Heart Journal|February 2, 2020
Incidence, underlying conditions, and outcomes of patients receiving acute renal replacement therapies in tertiary cardiac intensive care units: An analysis from the Critical Care Cardiology Trials Network RegistrySean van Diepen, Wayne Tymchak, Erin A Bohula, et al.
Nature|April 7, 2022
Multifunctional biocatalyst for conjugate reduction and reductive aminationThomas W Thorpe, James R Marshall, Vanessa Harawa, et al.
Translational Vision Science & Technology|September 8, 2021
Efficacy, Toxicity, and Pharmacokinetics of Intra-Arterial Chemotherapy Versus Intravenous Chemotherapy for Retinoblastoma in Animal Models and PatientsAnthony B Daniels, Michael T Froehler, Jessica V Kaczmarek, et al.
Journal of the American College of Cardiology|November 3, 2022
Implementation of High-Sensitivity Cardiac Troponin Assays in the United StatesCian McCarthy, Shuang Li, Tracy Y Wang, et al.
Medical Physics|September 10, 2019
Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC)Chenbin Liu, Nathan Y Yu, Jie Shan, et al.
Pageof 51